Phathom Pharmaceuticals News - PHAT

Company Name	Stock Ticker Symbol	Market	Type
Phathom Pharmaceuticals Inc	PHAT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	9.01	04:29:23

Open Price	Low Price	High Price	Close Price	Prev Close
				9.01

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/03/2024	08:00	GLOBE	Phathom Pharmaceuticals to Participate in the 23rd Annual..
3/26/2024	08:00	GLOBE	Phathom Pharmaceuticals Launches Direct-to-Consumer..
3/07/2024	16:01	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/2024	08:06	EDGAR2	Form 8-K - Current report
3/07/2024	08:00	GLOBE	Phathom Pharmaceuticals Reports Fourth Quarter and Full Year..
2/29/2024	08:00	GLOBE	Phathom Pharmaceuticals to Report Fourth Quarter and Full..
2/13/2024	08:05	EDGAR2	Form 8-K - Current report
2/13/2024	08:00	GLOBE	Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
1/31/2024	08:00	GLOBE	Phathom Pharmaceuticals to Present at the Guggenheim..
1/22/2024	20:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	16:05	EDGAR2	Form 8-K - Current report
12/14/2023	08:05	EDGAR2	Form 8-K - Current report
12/14/2023	08:00	GLOBE	Phathom Pharmaceuticals Announces Expansion of Existing Loan..
12/06/2023	08:05	EDGAR2	Form 8-K - Current report
12/06/2023	08:00	GLOBE	Phathom Pharmaceuticals Announces FDA Acceptance for Filing..
11/28/2023	08:06	EDGAR2	Form 8-K - Current report
11/28/2023	08:00	GLOBE	Phathom Pharmaceuticals Announces Commercial Availability of..
11/20/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/09/2023	16:02	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/09/2023	08:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	08:05	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	GLOBE	Phathom Pharmaceuticals Reports Third Quarter 2023 Results..
11/08/2023	19:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	16:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/01/2023	17:50	DJN	Phathom Pharmaceuticals Gets FDA Approval for Voquezna..
11/01/2023	17:06	EDGAR2	Form 8-K - Current report
11/01/2023	17:00	GLOBE	Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
10/30/2023	08:05	EDGAR2	Form 8-K - Current report
10/30/2023	08:00	GLOBE	Phathom Pharmaceuticals Announces FDA Approval of..
10/25/2023	08:01	GLOBE	Phathom Pharmaceuticals to Participate in Upcoming Investor..
9/26/2023	08:05	EDGAR2	Form 8-K - Current report
9/26/2023	08:01	GLOBE	Phathom Pharmaceuticals Announces Vonoprazan NDA Submission..
9/05/2023	08:00	GLOBE	Phathom Pharmaceuticals to Participate in Upcoming Investor..
8/21/2023	08:07	EDGAR2	Form 8-K - Current report
8/21/2023	08:00	GLOBE	Phathom Pharmaceuticals Announces Submission of Six-Month..
8/10/2023	16:02	EDGAR2	Form 8-K - Current report
8/10/2023	08:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:01	GLOBE	Phathom Pharmaceuticals Reports Second Quarter 2023 Results
7/17/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/17/2023	16:04	EDGAR2	Form 8-K - Current report
7/17/2023	16:02	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
6/12/2023	09:04	DJN	FDA Accepts Phathom Pharmaceuticals' Resubmission for..
6/12/2023	08:01	GLOBE	Phathom Pharmaceuticals Announces FDA Acceptance of NDA..
6/09/2023	16:01	GLOBE	Phathom Pharmaceuticals Announces Closing of Underwriters’..
6/09/2023	05:45	PRNUS	PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
6/07/2023	05:45	PRNUS	INVESTIGATION ALERT: The Gross Law Firm Notifies..
6/02/2023	05:45	PRNUS	PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
6/01/2023	08:00	GLOBE	Phathom Pharmaceuticals to Participate in Upcoming Investor..
5/30/2023	05:00	PRNUS	PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
5/26/2023	05:00	PRNUS	INVESTIGATION ALERT: The Gross Law Firm Notifies..